Varenicline tartrate 1 mg/1 (Varenicline tartrate TABLET, FILM COATED) 1 mg/1

Varenicline tartrate 1 mg tablets aid in smoking cessation by reducing cravings and withdrawal symptoms. This prescription medication is designed to support quitting smoking.

Strength

1 mg/1

Pack Size

56 TABLET, FILM COATED in 1 BOTTLE (14445-154-56)

Manufacturer / TM Owner

Indoco Remedies Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Varenicline tartrate is primarily used to help individuals quit smoking. It works by targeting nicotine receptors in the brain, which can help reduce the urge to smoke and alleviate withdrawal symptoms. This medication is often part of a comprehensive smoking cessation plan, which may include behavioral therapy and support.

Side Effects

Common effects of varenicline tartrate may include nausea, headache, and trouble sleeping. Some users may also experience changes in taste or vivid dreams. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

Varenicline tartrate should be used under medical supervision. It is important to follow the prescribed dosage and not to exceed it. Individuals with a history of mental health conditions should discuss their medical history with their healthcare provider before starting this medication.

Avoid Interactions

Varenicline tartrate may interact with certain medications, including those metabolized by the liver's CYP450 enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be minimized while using this medication.

Frequently Asked Questions

Varenicline tartrate is used to help people quit smoking by reducing cravings and withdrawal symptoms.

Varenicline tartrate is typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include nausea, headache, and trouble sleeping. These effects usually diminish over time.

Varenicline tartrate may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Varenicline tartrate should be used under medical supervision, especially for individuals with a history of mental health conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.